Chemoinformaics analysis of Methyl-Ent-8beta-Hydroxy-Labd-E-13-En-15-Oate
| Molecular Weight | 366.542 | nRot | 6 |
| Heavy Atom Molecular Weight | 328.238 | nRig | 13 |
| Exact Molecular Weight | 366.277 | nRing | 2 |
| Solubility: LogS | -4.334 | nHRing | 0 |
| Solubility: LogP | 4.254 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 65.2861 |
| nHD | 1 | BPOL | 42.4619 |
| QED | 0.546 |
| Synth | 4.54 |
| Natural Product Likeliness | 2.052 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.989 |
| Pgp-sub | 0.004 |
| HIA | 0.005 |
| CACO-2 | -4.702 |
| MDCK | 0.0000244 |
| BBB | 0.696 |
| PPB | 0.633371 |
| VDSS | 0.657 |
| FU | 0.415756 |
| CYP1A2-inh | 0.058 |
| CYP1A2-sub | 0.464 |
| CYP2c19-inh | 0.347 |
| CYP2c19-sub | 0.903 |
| CYP2c9-inh | 0.49 |
| CYP2c9-sub | 0.244 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.225 |
| CYP3a4-inh | 0.838 |
| CYP3a4-sub | 0.576 |
| CL | 6.702 |
| T12 | 0.643 |
| hERG | 0.03 |
| Ames | 0.014 |
| ROA | 0.069 |
| SkinSen | 0.912 |
| Carcinogencity | 0.108 |
| EI | 0.51 |
| Respiratory | 0.972 |
| NR-Aromatase | 0.011 |
| Antiviral | Yes |
| Prediction | 0.749715 |